The National Agency for Food and Drug Administration and Control has approved the use of the Johnson and Johnson COVID-19 vaccine in Nigeria.
The Director-General of the agency, Prof Moji Adeyeye, disclosed in a statement issued on Tuesday, 17th of May, 2021, signed by the agency’s spokesperson, Dr. Abubakar Jimoh.
The statement was titled “NAFDAC grants emergency use authorization for the ‘Johnson and Johnson’ vaccine’
The statement read, “NAFDAC is hereby granting conditional emergency use authorization for Johnson and Johnson Covid-19 vaccine to prevent COVID-19 in people from 18 years of age.
“After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety, and quality.”
According to the statement by the Director-General, data has also shown that the benefits of the vaccine outweigh its potential risk hence the reason for approval.
She also said that results from a clinical trial involving people in the United States, South Africa, and Latin America countries have shown that Johnson and Johnson Covid-19 vaccine was very useful in preventing Covid-19 in people from 18 years of age.
Unlike the AstraZeneca Vaccine which is administered in two doses, the Johnson and Johnson vaccine is administered in a single dose.